Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma

Leuk Lymphoma. 2016;57(4):842-51. doi: 10.3109/10428194.2015.1083098. Epub 2015 Dec 15.

Abstract

Diffuse large B-cell lymphoma (DLBCL) demonstrates significant racial differences in age of onset, stage, and survival. To examine whether population-specific models improve prediction of outcomes for African-American (AA) patients with DLBCL, we utilized Surveillance, Epidemiology, and End Results data and compared stratification by the international prognostic index (IPI) in general and AA populations. We also constructed and compared prognostic models for general and AA populations using multivariable logistic regression (LR) and artificial neural network approaches. While the IPI adequately stratified outcomes for the general population, it failed to separate AA DLBCL patients into distinct risk groups. Our AA LR model identified age ≥ 55 (odds ratio 0.45, [95% CI: 0.36, 0.56], male sex (0.75, [0.60, 0.93]), and stage III/IV disease (0.43, [0.34, 0.54]) as adverse predictors of 5-year survival for AA patients. In addition, general-population prognostic models were poorly calibrated for AAs with DLBCL, indicating a need for validated AA-specific prognostic models.

Keywords: Lymphoma; outcomes; prognostication; race; risk; survival.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Black or African American*
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / diagnosis
  • Lymphoma, Large B-Cell, Diffuse / epidemiology*
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Male
  • Middle Aged
  • Models, Statistical
  • Neoplasm Staging
  • Patient Outcome Assessment
  • Population Surveillance*
  • Prognosis
  • Risk
  • SEER Program